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Abstract
Background:  In  patients  with  unresectable  gastric  cancer  and  outlet  obstruction  syndrome,
gastric partitioning  gastrojejunostomy  is  an  alternative,  which  could  avoid  the  drawbacks  of
the standard  techniques.
Objective:  Comparison  of  antroduodenal  stent,  conventional  gastrojejunostomy  and  gastric
partitioning  gastrojejunostomy.
Material  and  methods:  A  retrospective,  cross-sectional  study  was  conducted  on  patients  with
unresectable  distal  gastric  cancer  and  gastric  outlet  obstruction,  treated  with  the  three  dif-
ferent techniques  over  the  last  12  years,  comparing  results  based  on  oral  tolerance  and
complications.  An  analysis  was  performed  on  the  results  using  the  Student’s  t  test  for  inde-
pendent  variables.
Results:  The  22  patients  were  divided  in  3  groups:  group  I  (6  cases)  stent,  group  II  (9  cases)
conventional  gastrojejunostomy,  and  group  III  (7  cases)  gastric  partitioning  gastrojejunostomy,
respectively.
The stent  allows  a  shorter  ‘‘postoperative’’  stay  and  early  onset  of  oral  tolerance  (p  <  0.05),
however,  the  gastric  partitioning  gastrojejunostomy  achieve  normal  diet  at  15th  day  (p  <  0.05).
The mortality  rate  was  higher  in  the  stent  group  (33%)  compared  with  surgical  techniques,
with a  morbidity  of  4/6  (66.7%)  in  group  I,  6/9  (66.7%)  group  II,  and  3/7  (42%)  group  III.  Re-
interventions:  2/6  group  I,  3/9  group  II,  and  0/7  group  III.  The  median  survival  was  superior  in
the gastric  partitioning  gastrojejunostomy,  achieving  an  overall  survival  of  6.5  months.
 Please cite this article as: Abdel-lah-Fernández O, Parren˜o-Manchado FC, García-Plaza A, Álvarez-Delgado A. Gastro yeyuno anasto-
osis con separación gástrica parcial en el tratamiento de la obstrucción gastroduodenal secundaria a cáncer gástrico avanzado. Cir Cir.
015;83:386--392.
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Conclusions:  The  gastric  partitioning  gastrojejunostomy  for  treatment  of  gastric  outlet  obstruc-
tion in  unresectable  advanced  gastric  cancer  is  a  safe  technique,  allowing  a  more  complete  diet
with lower  morbidity  and  improved  survival.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Published  by  Masson  Doyma  México  S.A.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Gastro  yeyuno  anastomosis  con  separación  gástrica  parcial  en  el  tratamiento  de  la
obstrucción  gastroduodenal  secundaria  a  cáncer  gástrico  avanzado
Resumen
Antecedentes:  En  pacientes  con  cáncer  gástrico  irresecable  con  obstrucción  antral,  la  gas-
tro yeyuno  anastomosis  con  separación  gástrica  parcial  es  una  alternativa,  que  evitaría  los
inconvenientes  de  las  técnicas  habituales.
Objetivo:  Comparar  stent  antroduodenal,  gastro-yeyuno-anastomosis  convencional  y  gastro-
yeyuno-anastomosis  con  separación  parcial  gástrica.
Material  y  métodos:  Estudio  retrospectivo  durante  12  an˜os,  transversal  en  enfermos  con  cáncer
gástrico  distal  irresecable  y  obstrucción  gástrica;  tratados  con  3  técnicas  diferentes,  compara-
ndo sus  resultados  en  función  de  la  tolerancia  oral  y  las  complicaciones.  Se  analizaron  los
resultados  con  la  t  de  Student  para  variables  independientes.
Resultados:  Veintidós  pacientes  divididos  en  3  grupos:  grupo  I  stent  (6  casos),  grupo  II  (9  casos)
gastro yeyuno  anastomosis  convencional  y  grupo  III  (7  casos)  gastro  yeyuno  anastomosis  con
separación  gástrica  parcial.
El  stent  permite  una  estancia  «postoperatoria» más  corta  e  inicio  de  la  tolerancia  de  alimentos
precoz (p  <  0.05).  La  gastro  yeyuno  anastomosis  con  separación  gástrica  parcial  permite  una
dieta normal  a  los  15  días  (p  <  0.05).  La  mortalidad  fue  superior  en  el  stent  (33%),  comparada
con las  técnicas  quirúrgicas.  La  morbilidad  fue  4/6  (66.7%)  en  el  grupo  I,  6/9  (66.7%)  en  el  grupo
II y  3/7  (42%)  en  el  grupo  III.  Las  reintervenciones:  2/6  grupo  I,  3/9  en  el  grupo  II  y  0/7  en  el
grupo III.  La  supervivencia  media  fue  superior  (6.5  meses)  en  grupo  III.
Conclusiones:  La  gastro  yeyuno  anastomosis  con  separación  gástrica  parcial  en  la  obstrucción
gástrica  por  cáncer  gástrico  avanzado  irresecable  es  una  técnica  segura,  permitiendo  una  dieta
más completa  con  menor  morbilidad  y  mejor  supervivencia.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este
es un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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neural  factors  which  delay  gastric  emptying,  which  variesBackground
In  patients  with  unresectable  gastric  cancer  and  outlet
obstruction  syndrome,  partial  stomach-partitioning  gastro-
jejunostomy  is  an  alternative  which  could  resolve  the
obstruction  and  is  an  alternative  that  might  avoid  the  draw-
backs  of  the  standard  techniques.
In  cases  of  advanced,  unresectable  distal  gastric  cancer,
with  outlet  obstruction,  even  in  cases  where  an  associated
resection  of  the  neighbouring  tissues  or  organs  has  been  per-
formed,  it  is  not  realistic  to  expect  increased  survival;  yet
there  are  increased  postoperative  complications.1
Gastric  cancer  is  the  second  most  common  cause  of
death  worldwide.  When  it  presents  as  gastric  obstruction
syndrome,  it  causes  nausea,  vomiting,  loss  of  appetite  and
malnutrition,  which  have  a  negative  impact  on  the  survival
and  quality  of  life  of  these  patients.  It  is  also  associated
with  a  poor  clinical  course  and  prognosis  even  when  curative
resections  are  performed.2
f
o
rAlthough  chemotherapy  is  the  initial  treatment  in  cases
f  advanced  gastric  cancer,  the  symptoms  associated  with
astric  obstruction  cause  digestive  intolerance  which  makes
ral  chemotherapy  regimens  impossible,  therefore,  in  this
linical  situation,  the  most  appropriate  initial  treatment
ppears  to  be  surgical  or  endoscopic.2,3 In  these  cases,  other
alliative  solutions  include  placing  an  antroduodenal  stent
r  bypass  surgery,  and  traditionally  conventional  gastroje-
unostomy  is  indicated  in  order  to  improve  quality  of  life
nd  to  enable  these  patients  food  intake.  A  good  result  is
chieved  in  over  70%  of  cases.4,5 Conventional  bypass  surgery
as  been  the  standard  palliative  treatment  for  gastric  outlet
bstruction  syndrome  in  unresectable  gastric  cancer.  Occa-
ionally  this  surgical  drainage  is  not  completely  effective
n  relation  to  oral  intake,  because  it  is  associated  withrom  3%  to  31%  in  recent  studies6; therefore,  up  to  a  third
f  patients  operated  using  this  traditional  technique  expe-
ience  no  palliation  of  their  symptoms.  Antrectomy  with
3 O.  Abdel-lah-Fernández  et  al.
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Table  1  Demographic  data,  and  relationship  between
onset of  diet  and  type  of  diet  between  the  different  groups.
Group  I  Group  II  Group  III
Number  of  cases 6  9  7
Age (median) 70  75  77
Sex (F/M)  2/4  2/7  2/5
ASA (median)  3  3  3
Mean stay  7.5  days  14  days  13  days
Pre/post  albumin  4/2.9  3.3/2.4  3/2.7
Onset of  tolerance  2  days  6  days  6  days
Diet  at  15  days
(None/SL/Normal)
1/2/3  2/5/2  0/1/6
ASA: American Society of Anesthesiologists; M: Males; F:
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astrojejunostomy  or  the  Devine  exclusion  procedure  has
roved  an  effective  alternative  to  traditional  gastrojejun-
stomy,  as  it  enables  better  oral  intake  in  these  cases,7,8
owever  it  does  have  some  drawbacks  in  that  it  requires  a
rainage  tube  in  the  distal  gastric  remnant  if  the  antrum  is
otally  occluded,  and  it  is  impossible  to  perform  this  tech-
ique  if  the  minor  curvature  has  been  inﬁltrated.  In  1997
aminishi  et  al.,9 with  a  view  to  resolving  these  problems,
resented  a  surgical  technique  modifying  the  Devine  pro-
edure  which  consisted  of  a  partial  stomach-partitioning
astrojejunostomy.  Their  results  demonstrated  a  lower  rate
f  tumour  bleeding,  lower  delayed  gastric  emptying  rates
nd  greater  and  more  complete  oral  tolerance  than  conven-
ional  gastrojejunostomy.
Endoscopic  placement  of  a  self-expanding  metal  stent  is
ow  another  alternative.  This  results  in  a  more  rapid  res-
lution  of  symptoms  and  a  lower  morbidity  rate  after  the
rocedure,  but  the  drawbacks  with  this  option  have  been
escribed  as  the  recurrence  of  obstructive  symptoms  and  a
reater  need  for  reintervention.10
bjective
he  aim  of  this  study  was  to  compare  3  palliative  techniques
sed  to  treat  unresectable  gastric  cancer  and  outlet  obstruc-
ion  syndrome.  These  techniques  comprise  the  placement
f  an  antroduodenal  self-expandable  metallic  stent  (group
),  conventional  gastrojejunostomy  (group  II)  and  partial
tomach-partitioning  gastrojejunostomy,  Kaminishi’s  tech-
ique  modiﬁed  (group  III).  We  assessed  the  outcomes  of  the
echniques,  principally  focussing  on  efﬁcacy  in  terms  of  oral
ntake,  unfavourable  incidents  and  impact  on  the  patients’
rogress.
aterial and methods
 retrospective,  cross-sectional  study  was  performed
n  which  the  patients  were  divided  into  3  groups  in
rder  to  compare  them  according  to  their  treatment.
e  reviewed  patients  treated  with  conventional  gastro-
ejunostomy  (group  II)  and  partial  stomach-partitioning
astrojejunostomy,  (group  III)  with  unresectable  gastric  can-
er  and  outlet  obstructive  syndrome,  from  1  February  2000
o  1  February  2012,  in  the  University  Health  Complex  of  Sala-
anca,  Spain.  A  group  of  patients  was  added  randomly,  with
he  same  diagnosis  and  clinical  situation,  who  had  been  ﬁt-
ed  with  a  stent  (group  I).  We  attempted  to  ensure  that  this
roup  was  homogeneous  in  terms  of  number  with  the  other
 groups  (Table  1).
Patients  were  included  who  had  been  diagnosed  with
nresectable  gastric  cancer  with  clinical  data  of  gas-
ric  obstruction,  and  deﬁned  as  patients  presenting  with
dvanced,  unresectable  gastric  cancer  greatly  exceeding
he  pylorus  and  the  ﬁrst  duodenal  portion,  with  spread  to
eighbouring  and  vascular  structures  or  with  distant  metas-
asis,  originating  in  the  distal  gastric  third  (antropyloric
egion)  associated  with  nausea,  vomiting  and  digestive  intol-
rance.
l
(
f
g
tFemales; SL: semi-liquid diet.
Intake  was  assessed  from  its  onset  and  at  15  days  from
he  date  of  the  procedure  using  the  following  scale:  0:  no
iet,  1:  semi-liquid  diet,  2:  puréed  or  normal  diet  based  on
he  scale  of  gastric  obstruction.
Pancreatic-duodenal  tumours,  recurrent  gastric  tumours
nd  patients  who  had  been  ﬁtted  with  a  gastroduodenal
tent  prior  to  surgery  were  excluded.
The  results  were  analysed  statistically  using  the  Student’s
 test  for  independent  variables.
urgical  technique
)  In  group  I  the  stent  was  placed  under  sedation;  this  was
a  self-expandable  metallic  stent  in  the  antroduodenal
region  (Wallstent  Boston  ScientiﬁcTM).
)  A  routine  gastrojejunostomy  was  performed  in  group  II,
manual  transmesocolic  wherever  possible,  in  the  free
gastric  portion  plus  the  dependent  portion  in  order  to
enable  gastric  emptying.
)  In  group  III  the  partial  stomach-partitioning  gastroje-
junostomy  was  performed  via  a  limited  supraumbilical
midline  laparotomy  of  less  than  10  cm.  After  freeing  and
sectioning  the  gastroepiploic  ligament  in  the  greater  gas-
tric  curvature,  proximal  and  near  to  the  tumour,  the
stomach  was  partially  divided  using  an  EndoGIA  60  mm
stapler  towards  the  lower  curvature  leaving  a  distance
of  3  cm.  The  tract  was  reconstructed  using  (transme-
socolic  or  anticolic)  latero-lateral  Roux  en  Y  technique
in  the  posterior  gastric  wall  at  2  cm  from  the  proximal
branch,  parallel  to  the  inverted  V,  and  the  foot  of  the
loop  was  made  using  an  EndoGia  35  mm  vascular  stapler
(Fig.  1).
At  the  end  of  this  procedure  we  also  placed  a  double-
umen  naso-gastrojejunal  tube  with  gastric  aspiration
Compact® Stay-put  9/18FR  Nestlé  Health  Care  Nutrition)
or  early  postoperative  enteral  feeding.
Neither  conventional  nor  partial  stomach-partitioning
astrojejunostomies  were  ever  performed  on  macroscopic
umour  tissue.
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treated  in  group  II  (11.2%)  1/9,  and  to  those  of  group  IIIFigure  1  Partial  stomach-partitioning  gastrojejunostomy
technique  and  Roux  en  y  reconstruction.
Results
The  clinical  characteristics  of  the  22  patients  and  their
distribution  into  the  different  groups  are  summarised  in
Table  1,  16  men  and  6  women,  with  an  average  age  of  74.
Table  1  also  shows  the  demographic  results  and  the  most
relevant  data  of  the  groups,  and  it  can  be  observed  that
there  are  no  signiﬁcant  differences  in  terms  of  age,  gender
(
d
q
Table  2  Histological  characteristics  and  tumour  stage.
Group  I  Grou
Laurent
Intestinal  1  4  
Diffuse 3  3  
Mixed 2  2  
TNM
T4a 1  4  
T4b 5  5  
N2 0  1  
N3 1  3  
Nx 5  5  
M0 1  4  
M1 5  5  
Liver Mx  4  2  
Carcinomatosis  1  3  
Stage
IIIc 1  (17)  4  (56
IV 5  (83)  5  (44 of  the  malignantgastric  outlet  obstruction  389
nd  the  American  Society  of  Anesthesiologists  between  the
roups.
Table  2  shows  the  groups’  anatomopathological  charac-
eristics  and  tumour  stage.  The  histological  type  according
o  Laurent’s  classiﬁcation  shows  a  homogeneous  distribu-
ion  between  the  groups,  36.4%  being  intestinal  and  the
ame  percentage  in  the  diffuse  ones.  Of  the  22  patients,
6  (72.7%)  presented  distant  disease  at  the  time  of  inter-
ention  and  were  at  stage  IV,  and  locoregional  involvement
f  the  tumour  was  so  extensive  in  6  (27.2%),  stage  IIIc,  it
as  considered  unresectable;  this  circumstance  occurred  in
6%  of  the  patients  in  group  II,  whereas  in  group  I  and  group
II  it  occurred  in  17%  and  14%  respectively.
None  of  the  patients  received  neoadjuvant  treatment;
owever,  they  had  presented  with  obstructive  syndrome
rom  the  outset  or  had  received  palliative  adjuvant  treat-
ent  and  presented  progression  of  the  disease.  Fifteen
68%)  patients  received  chemotherapy  subsequently,  of  the
 (32%)  patients  who  were  not  given  chemotherapy  3  were
rom  group  I  and  group  II  respectively,  and  one  from  group
II.
When  the  results  of  the  techniques  were  assessed  it  was
hown  that  the  stent  resulted  in  a  shorter  postoperative
tay  and  earlier  onset  of  oral  tolerance  (p  <  0.05)  compared
o  the  other  techniques.  In  relation  to  the  type  of  diet
fter  15  days,  we  found  signiﬁcant  differences  with  par-
ial  stomach-partitioning  gastrojejunostomy  where  a  more
omplete  diet  was  achieved  after  15  days  and  with  greater
requency  (p  <  0.05).
With  regard  to  the  complications  which  are  summarised
n  Table  3,  we  observed  that  mortality  was  greater  in  the
atients  treated  in  group  I  (33%)  2/6,  compared  to  those14%)  1/7  respectively.  In  the  surgical  groups  mortality  was
ue  to  medical  complications.  Early  morbidity  was  less  fre-
uent  and  severe  than  in  group  III;  principally  due  to  surgical
p  II  Group  III  Overall  (%)
3  8  (36.4)
2  8  (36.4)
2  6  (27.2)
2  7  (32)
5  15  (68)
0  1
3  7
4  14
1  6  (27.2)
6  16  (72.7)
2  8
5  9
)  1  (14)  6  (27.2)
)  6  (86)  16  (72.7)
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Table  3  Complications  between  the  different  groups.
Group  I  Group  II  Group  III
Mortality  n  (%)  2/6  (33)  1/9  (11.2)  1/7  (14)
Cause Pneumonia
Perforation
Pneumonia  Pneumonia
Morbidity Patients  4/6  (67%)  6/9  (67%)  3/7  (43%)
Delayed gastric  emptying  1  (17%)  3  (33%)  1  (14%)
Restenosis  1  0  0
Obstruction  0  2  0
Perforation  2  0  0
Dehiscence  0  1  0
Haemorrhage  2  1  0
SSI 0  1  3
UTI 0  1  0
Reinterventions  2  3  0
SSI: surgical site infection; UTI: urinary tract infection.
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pite  infection.  Delayed  gastric  emptying  presented  more  fre-
uently  in  group  II  (33%).
Five  patients  were  reoperated:  3  (33%)  patients  from
roup  II  (one  due  to  anastomotic  dehiscence  and  the  other
wo  due  to  obstruction  of  the  afferent  loop)  and  2  (33%)
atients  in  group  I:  one  case  as  a  consequence  of  duodenal
erforation  and  the  other  due  to  restenosis  and  perforation
econdary  to  the  restenosis.  None  of  the  patients  in  group
II,  required  reintervention  (Table  3).
Mean  survival  was  2.5  (0.5--6)  months  in  group  I,  3  (0--6)
onths  in  group  II  and  6.5  (0.5--20)  months  in  group  III,  with
o  statistically  signiﬁcant  value.
iscussion
alliative  surgery  (gastric  resection)  for  incurable  stomach
ancer  depends  on  the  general  condition  of  the  patient
nd  the  extent  of  progression  of  the  cancer,  it  has  been
stimated  that  in  5--31%  of  patients  with  stomach  cancer
t  is  not  possible  to  resect  the  primary  lesion1;  moreover
hen  it  presents  as  secondary  obstruction  syndrome,  it
s  associated  with  spread  to  neighbouring  organs  in  47%,
ith  lymph  node  involvement  in  93%,  carcinomatosis  in
4%  and  with  15%  liver  metastases.3 These  percentages
re  higher  in  our  series,  41%  carcinomatoses  and  36%  liver
etastases.  Routine  treatment  is  conventional  gastrojejun-
stomy  which  has  the  drawback  that  10%  to  50%  of  patients
resent  signiﬁcant  delayed  gastric  emptying7,11,12 (33%  in  our
xperience).
In  1925,  Devine13 introduced  gastrojejunostomy  with
ntral  exclusion  for  the  treatment  of  unresectable  duode-
al  ulcer,  which  was  subsequently  applied  to  unresectable
ancerous  gastroduodenal  lesions  with  the  following  bene-
ts:  making  an  anastomosis  far  from  the  primary  tumour  to
solate  the  tumour  from  food  and  acid  in  order  to  reduce
he  possibility  of  bleeding.14 The  disadvantage  of  this  tech-
ique  was  the  need  to  decompress  the  isolated  antrum  with
 probe.
In 1997,  Kaminishi  et  al.9 modiﬁed  Devine’s  technique,
escribing  partial  stomach-partitioning  gastrojejunostomy
t
i
s
to  achieve  minimal  contact  of  food  and  gastric  acid  with  the
umour,  as  well  as  improving  gastric  emptying,  and  enabling
ndoscopic  assessment  of  the  lesion.
In  this  article  we  present  our  experience  with  par-
ial  stomach-partitioning  gastrojejunostomy  as  described  by
aminishi  et  al.9 modiﬁed,  performing  a  termino-lateral
astrojejunostomy  on  the  posterior  wall,  in  the  proximal
ortion  of  the  gastric  channel  and  a  termino-lateral  Roux
n  Y  anastomosis  at  the  foot  of  the  loop  (Fig.  1).  The  reason
or  modifying  the  original  technique  is  to  reduce  the  blind
oop  effect  in  the  afferent  loop  of  the  gastrojejunostomy
nd  enable  gastric  emptying.  Several  published  studies  indi-
ate  that  the  use  of  Roux  en  Y  loop  minimises  delayed
astric  emptying  and  reduces  the  postoperative  hospital
tay.15
Our  results  show  fewer  cases  of  delayed  gastric  emptying
n  group  III  (14%)  compared  to  group  II  (33%)  and  group  I
17%).
As  demonstrated  in  other  studies,9,16 the  stent  achieves
 similar  percentage  of  success  in  resolving  symptoms  and
hey  coincide  with  our  results  in  that  this  group  of  patients
resented  a  shorter  hospital  stay  and  more  rapid  onset  of
ral  tolerance  (p  <  0.05)  in  comparison  with  the  surgical
echniques;  but  we  observed  in  this  study  that  the  stent
esults  are  not  maintained  over  time,  as  only  50%  of  cases
olerated  a  complete  diet  after  15  days.  These  results  have
lso  been  described  in  other  studies,  where  this  technique
s  associated  with  more  long-term  complications,  these
nclude  lower  duration  of  the  permeability  of  the  prosthesis
ven  when  an  additional  one  is  placed,  and  lower  survival,
specially  in  patients  with  a better  general  condition11.  This
oincides  with  our  results  in  that  the  patients  of  group  I
ad  greater  mortality  compared  to  the  groups  using  surgical
echniques  (group  II  and  group  III).
In  our  opinion,  this  technique  should  be  reserved  for
atients  with  a  poor  clinical  situation  and  poor  overall
rognosis,  whereas  patients  with  a  better  clinical  condi-
ion  should  be  offered  gastric  bypass  surgery.  This  opinion
s  shared  by  other  authors,  who  recommend  that  a  stent
hould  be  used  when  the  patient’s  life  expectancy  is  less
han  2  months.3,17
ent
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domized trial. Gastrointest Endosc. 2010;71:490--9.Partial  stomach  partitioning  gastrojejunostomy  in  the  treatm
Most  publications  which  compare  stents  with  gastrojejun-
ostomy  do  not  specify  the  type  of  surgical  bypass  performed
in  surgical  patients,  and  they  include  patients  with  symp-
toms  of  gastric  obstruction  secondary  to  a  cancer,  but  the
origin  of  the  primary  tumour  is  variable,  principally  pancre-
atic,  which  has  a  poorer  prognosis.11,18
Our  results  show  that  partial  stomach-partitioning  gas-
trojejunostomy  ensures  that  the  diet  of  these  patients  at
15  days  is  more  complete,  with  greater  frequency  (85%)
(p  <  0.05);  this  fact  is  related,  as  observed  by  Kubota  et  al.,
19 to  better  quality  of  life  and  a  better  prognosis.
Onset  of  tolerance  was  on  the  sixth  postoperative  day
with  the  surgical  techniques.  In  group  III  we  thought  that
onset  of  tolerance  was  delayed  through  the  routine  use
of  a  double-lumen  naso-gastrojejunal  tube  with  gastric
aspiration  (Compact® Stay-put  9/18FR  Nestlé  HealthCare
Nutrition)  and  early  postoperative  enteral  feeding.
We  have  seen  how  with  partial  stomach-partitioning
gastrojejunostomy  fewer  overall  complications  tend  to
develop,  and  they  are  less  severe,  there  is  less  need
for  reintervention  and  there  is  even  better  survival  than
with  the  other  2  techniques,  although  with  no  signiﬁcant
differences.  Okumura  et  al.3 achieved  a  mean  overall  sur-
vival  of  8.8  months  in  25  patients  with  obstructive  gastric
cancer  treated  with  partial  stomach-partitioning  gastro-
jejunostomy,  and  this  directly  related  with  the  presence
of  complications  and  the  lack  of  chemotherapy  treat-
ment;  patients  with  complications  are  often  not  given
chemotherapy.  Our  mean  survival  was  6.5  months  in
group  III.
We  must  state  that  this  study  is  limited  by  the  reduced
number  of  patients  in  the  different  groups,  but  this  is
a  consequence  of  the  small  percentage  of  patients  with
these  circumstances;  obstruction  secondary  to  antropyloric
adenocarcinomas  which  are  unresectable  is  rare;  in  the
series  of  Okumura  et  al.3 they  comprised  6.3%  of  all  the  gas-
tric  cancers  treated  over  11  years.  In  the  systematic  review
which  was  undertaken  by  Zheng  et  al.18 from  1996  to  2010,
the  cases  of  gastric  cancer  with  these  characteristics  did
not  exceed  10  patients  and  this  is  reﬂected  in  this  study
after  collecting  cases  retrospectively  over  12  years.  Remem-
ber  that  only  patients  with  gastric  cancer  were  included  in
the  study,  in  order  to  be  more  homogeneous,  although  this
technique  can  also  be  applied  to  duodenal  and  pancreatic
tumours.6,20,21
In  conclusion,  partial  stomach-partitioning  gastrojejuno-
stomy  for  the  treatment  of  gastric  obstruction  in  advanced,
unresectable  gastric  cancer  is  a  technique  which  is  at
least  as  safe  as  the  compared  techniques  (conventional
gastrojejunostomy  and  stent),  and  also  allows  a  more  com-
plete  diet  in  a  greater  number  of  patients  with  lower
morbidity  and  better  survival,  and  therefore  should  be
the  most  appropriate  technical  option  for  patients  with
obstructive  symptoms  secondary  to  unresectable  gastric
cancer  with  an  acceptable  clinical  situation  and  better
prognosis.Conﬂict of interests
The  authors  have  no  conﬂict  of  interests  to  declare.
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